CUSTOMER SUPPORT

4DMEDICAL

Latest News

Learn about 4DMedical’s latest developments and future projects as well—all aimed at significantly improving early detection, diagnosis, and therapeutic strategies for a range of pulmonary conditions, including chronic obstructive pulmonary disease (COPD), asthma, and lung cancer.
SimonMed and 4DMedical Announce Nationwide Launch -News Thumbnail
02 November 2026

SimonMed launches CT:VQ and LDAf, expanding access to advanced lung imaging nationwide

Physicians can now order 4DMedical’s CT:VQ and LDAf analyses at SimonMed locations nationwide, gaining complementary functional and quantitative insights to support the evaluation of respiratory symptoms and lung disease. The clinical launch coincides with November’s COPD Awareness Month. As 4DMedical’s first nationwide outpatient imaging-group partner in the United States, SimonMed
READ MORE
17 August 2026

4DMedical and Azra AI Partner to Connect Lung Findings to Coordinated Care

4DMedical and Azra AI announce a strategic OEM and reseller partnership designed to help health systems identify patients with lung disease and connect them to the right care pathway sooner. Under the agreement, 4DMedical will resell Azra AI’s real-time patient identification and care coordination platform to its health system customers,
READ MORE
03 August 2026

AI Lung Cancer Risk Assessment Meets Functional Lung Imaging Through New 4DMedical-RevealDx Partnership

4DMedical has entered a distribution agreement and strategic investment partnership with RevealDx, bringing RevealAI-Lung into its expanding cardiopulmonary imaging ecosystem. RevealAI-Lung uses artificial intelligence to characterize pulmonary nodules and provide a Malignancy Similarity Index (mSI™) that helps radiologists make more informed follow-up recommendations. Together with 4DMedical's functional imaging technologies, the
READ MORE
01 August 2026

Nov 29 – Dec 2 | RSNA 2026 | Chicago, IL

See more in lung structure. Explore regional lung function. Join 4DMedical at RSNA 2026, November 29–December 2, at North Hall, Booth 6122. Discover our full portfolio, explore quantitative structural and non-contrast functional lung insights, and connect with our team about your thoracic imaging priorities.
READ MORE
15 July 2026

4DMedical Welcomes Introduction of AIR CARE for Veterans Act

4DMedical welcomes the introduction of the bipartisan AIR CARE for Veterans Act of 2026 (H.R. 9666), legislation that would direct the U.S. Department of Veterans Affairs to establish a pilot program using FDA-approved four-dimensional functional lung imaging technology to identify respiratory disorders and lung disease in veterans.
READ MORE
4DMedical CT:VQ - Ventilation and Perfusion Analysis - Maximum Contrast and No Injections
28 June 2026

4DMedical Receives TGA Approval for CT:VQ™, Expanding Access to Functional Lung Imaging in Australia

4DMedical receives TGA approval for CT:VQ™, the first non-contrast CT-based ventilation-perfusion imaging solution. Learn how CT:VQ™ expands access to functional lung imaging across Australia.
READ MORE
4DMedical and contextflow logos
01 June 2026

4DMedical Expands into Europe with Agreement to Acquire Software Lung Imaging Leader contextflow

4DMedical, a global leader in advanced respiratory imaging and lung analysis software, has signed a binding agreement to acquire contextflow GmbH, a Vienna-based medical software imaging company specializing in lung cancer detection, chest CT analysis and radiology workflow solutions. The acquisition establishes 4DMedical’s on-the-ground European commercial platform, adding an experienced
READ MORE
4DMedical’s CT:VQ™ technology combines the anatomical clarity of CT with functional ventilation-perfusion mapping from routine non-contrast CT scans, giving clinicians quantitative insights into regional lung function without radiotracers.
30 March 2026

4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union

4DMedical Limited (ASX:4DX), the global leader in cardiothoracic imaging software, announces that its latest imaging technology, CT:VQ™ has received CE Mark certification for commercial use in the European Union. 4DMedical will quickly launch commercial deployment of CT:VQ across one of the world's largest respiratory imaging markets.
READ MORE
The Surprising Faces of Lung Disease
29 March 2026

Not Just for Smokers: The Surprising Faces of Lung Disease

We may all be guilty of picturing the same person when we hear that someone has lung cancer—an older man who smoked for many years. The truth is, millions of people with lung disease have never smoked a single cigarette. Children, women who have never smoked, and even athletes can
READ MORE

What's new at 4DMedical

Get the latest news about respiratory imaging and ventilation analysis

CUSTOMER SUPPORT